IPC flags ADR linked to Nimesulide, Cefuroxime, Dutasteride plus Tamsulosin and some beta-blockers
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert, has revealed adverse drug reactions linked with the popular antibiotic Cefuroxime, fixed-dose combination drug Dutasteride plus Tamsulosin, non-steroidal anti-inflammatory drug Nimesulide, and beta blockers such as Metoprolol, Propranolol, Atenolol.
In accordance with the drug safety alert, Cefuroxime which is an antibiotic, indicated for lower and upper respiratory tract infections, urinary tract infections (UTI), gynecological infections, and skin or soft tissue infections, etc can cause Acute Generalized Exanthematous Pustulosis (AGEP).
For more information, click on the link below:
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.